# Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study

> **NCT03481413** · — · TERMINATED · sponsor: **EPD Solutions, A Philips Company** · enrollment: 566 (actual)

## Conditions studied

- Arrythmia

## Interventions

- **DEVICE:** Ablation

## Key facts

- **NCT ID:** NCT03481413
- **Lead sponsor:** EPD Solutions, A Philips Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-30
- **Primary completion:** 2023-03-30
- **Final completion:** 2023-03-30
- **Target enrollment:** 566 (ACTUAL)
- **Why stopped:** Philips decided to wind down the EPD Solutions business
- **Last updated:** 2023-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03481413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03481413, "Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03481413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*